NOVANTA CFO exercises options and sells 9,957 shares
NOVANTA INC Chief Financial Officer Robert Buckley exercised stock options covering 9,957 shares of common stock at $14.13 per share and, on the same day, sold 9,957 shares in multiple open-market transactions at prices between $116.02 and $118.80.
Rhea-AI Filing Summary
NOVANTA INC Chief Financial Officer Robert Buckley exercised stock options covering 9,957 shares of common stock at $14.13 per share and, on the same day, sold 9,957 shares in multiple open-market transactions at prices between $116.02 and $118.80. The filing notes these sales were effected under a pre-established Rule 10b5-1 trading plan adopted on March 13, 2025. After these transactions, Buckley holds 96,616 shares directly and 36,219 shares indirectly through the Buckley Family Irrevocable Trust.
Positive
- None.
Negative
- None.
Insights
CFO executes options and sells equal shares under a 10b5-1 plan.
Robert Buckley, CFO of NOVANTA INC, exercised stock options for 9,957 shares at an exercise price of $14.13 per share and sold the same number of shares in several open-market trades around $116–$119.
This is a classic exercise-and-sell pattern: a derivative position is converted into common stock and then monetized. The filing specifies that the sales occurred pursuant to a pre-established Rule 10b5-1 trading plan, indicating they were pre-scheduled rather than opportunistic.
Following the transactions, Buckley still owns 96,616 shares directly and 36,219 shares indirectly via the Buckley Family Irrevocable Trust. Given the remaining holdings and the pre-planned nature of the trades, this appears to be routine portfolio and compensation management rather than a thesis-changing signal.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 9,957 | $0.00 | $0.00 |
| Exercise | Common Stock | 9,957 | $14.13 | $141K |
| Sale | Common Stock | 3,215 | $116.02 | $373K |
| Sale | Common Stock | 4,719 | $116.84 | $551K |
| Sale | Common Stock | 1,937 | $117.74 | $228K |
| Sale | Common Stock | 86 | $118.80 | $10K |
| holding | Common Stock | -- | -- | -- |
Footnotes (6)
- F1. The sales reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
- F2. This transaction was executed in multiple trades ranging from $115.40 to $116.40. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades ranging from $116.41 to $117.40. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades ranging from $117.42 to $118.41. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades ranging from $118.53 to $119.02. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. The Stock Options vested in three equal installments on March 30, 2017, March 30, 2018, and March 30, 2019.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NOVANTA INC (NOVT) CFO Robert Buckley do in this Form 4 filing?
Were Robert Buckley’s NOVANTA (NOVT) stock sales part of a Rule 10b5-1 trading plan?
What stock options did NOVANTA (NOVT) CFO Robert Buckley exercise in this Form 4?
Does this NOVANTA (NOVT) Form 4 show any remaining stock options for Robert Buckley?
AI-generated analysis. How Rhea-AI works. Not financial advice.